Silicon nanotube arrays deliver functional mRNA into human pluripotent stem cells for the first time, achieving up to 64% transfection without compromising stem cell identity.

MIGDAL HA'EMEK, Israel, March 17, 2021 (GLOBE NEWSWIRE) -- PV Nano Cell, Ltd. (OTCPink: PVNNF) ("PV Nano Cell" or the "Company"), an innovative provider of inkjet-based conductive digital printing ...

In A Nutshell Researchers at Tokyo University of Science developed a method to create fluorescent, irregularly shaped ...

(Nanowerk News) How can we ensure that life-saving drugs or genetic therapies reach their intended target cells without causing harmful side effects? Researchers at Helmholtz Munich, ...

The manufacturing and deployment of hybrid and electric vehicles is on the rise, contributing to ongoing efforts to decarbonize the transport industry. While cars and smaller vehicles can be powered ...

MIGDAL HA'EMEK, Israel, Dec. 02, 2020 (GLOBE NEWSWIRE) -- PV Nano Cell, Ltd. (OTCQB: PVNNF) ("PV Nano Cell" or the "Company"), an innovative provider of inkjet-based conductive digital printing ...

SYDNEY (Reuters) - An Australian biotechnology firm said on Thursday it had developed a means of delivering anti-cancer drugs directly to cancer cells, which aims to avoid the debilitating toxicity ...

Stem cell therapy shows promise for silicosis by targeting fibrosis, immune imbalance, and lung function decline.